BTIS
ALXN

BB&T Investment Services’s Alexion Pharmaceuticals ALXN Stock Holding History

BB&T Investment Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$26K Buy
216
+67
+45% +$8.16K ﹤0.01% 731
2017
Q3 		$21K Buy
149
+24
+19% +$3.26K ﹤0.01% 714
2017
Q2 		$14K Sell
125
-119
-49% -$13.8K ﹤0.01% 729
2017
Q1 		$29K Buy
244
+125
+105% +$16.1K 0.01% 486
2016
Q4 		$14K Buy
+119
New +$14.6K 0.01% 485

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BB&T Investment Services's ALXN Position: Q4 2017 in Review

BB&T Investment Services increased its Alexion Pharmaceuticals (ALXN) stake by 45% in Q4 2017, buying an estimated $8.16K and bringing the position to 216 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

BB&T Investment Services first reported a position in ALXN in Q4 2016 and has held it in 5 quarters since. The position peaked at $29K in Q1 2017. 587 funds tracked by Wall St. Rank hold ALXN as of Q4 2017.

  • BB&T Investment Services held 216 shares of Alexion Pharmaceuticals worth $26K as of Q4 2017.
  • BB&T Investment Services bought 67 Alexion Pharmaceuticals shares in Q4 2017, an estimated $8.16K.
  • Alexion Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #731 holding.
  • BB&T Investment Services first reported a position in Alexion Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Alexion Pharmaceuticals position peaked at $29K in Q1 2017.
  • 587 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.